Menard Financial Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,888	Closed	-$211K	–	153
2021 Q3	$211K	Buy	1,888 +279	+17%	+$31.2K	0.18%	151
2021 Q2	$260K	Buy	+1,609	New	+$260K	0.25%	119
2021 Q1	–	Sell	-2,289	Closed	-$350K	–	140
2020 Q4	$350K	Buy	+2,289	New	+$350K	0.38%	83